Bioscience Animal Return On Equity vs. Price To Sales
| BIS Stock | 3.26 0.14 4.12% |
For Bioscience Animal profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Bioscience Animal to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Bioscience Animal Health utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Bioscience Animal's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Bioscience Animal Health over time as well as its relative position and ranking within its peers.
Bioscience |
Bioscience Animal Health Price To Sales vs. Return On Equity Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Bioscience Animal's current stock value. Our valuation model uses many indicators to compare Bioscience Animal value to that of its competitors to determine the firm's financial worth. Bioscience Animal Health is number one stock in return on equity category among its peers. It also is number one stock in price to sales category among its peers fabricating about 9.36 of Price To Sales per Return On Equity. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Bioscience Animal's earnings, one of the primary drivers of an investment's value.Bioscience Price To Sales vs. Return On Equity
Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Bioscience Animal |
| = | 0.12 |
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio, the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries.
Bioscience Animal |
| = | 1.13 X |
The most critical factor to remember is that the price of equity takes a firm's debt into account, whereas the sales indicators do not consider financial leverage. Generally speaking, Price to Sales ratio shows how much market values every dollar of the company's sales.
Bioscience Price To Sales Comparison
Bioscience Animal is currently under evaluation in price to sales category among its peers.
Bioscience Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Bioscience Animal. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Bioscience Animal position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Bioscience Animal's important profitability drivers and their relationship over time.
Use Bioscience Animal in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Bioscience Animal position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bioscience Animal will appreciate offsetting losses from the drop in the long position's value.Bioscience Animal Pair Trading
Bioscience Animal Health Pair Trading Analysis
The ability to find closely correlated positions to Bioscience Animal could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Bioscience Animal when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Bioscience Animal - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Bioscience Animal Health to buy it.
The correlation of Bioscience Animal is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Bioscience Animal moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Bioscience Animal Health moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Bioscience Animal can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Bioscience Animal position
In addition to having Bioscience Animal in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Macroaxis Index Thematic Idea Now
Macroaxis Index
An experimental equal-weighted index theme of selected equities generated based on Macroaxis rating and scoring system. The Macroaxis Index theme has 52 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Macroaxis Index Theme or any other thematic opportunities.
| View All Next | Launch |
Other Information on Investing in Bioscience Stock
To fully project Bioscience Animal's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Bioscience Animal Health at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Bioscience Animal's income statement, its balance sheet, and the statement of cash flows.